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When hormones during the ovulatory cycle are shown in phase plane graphs,
reported FSH and estrogen values form a specific pattern that resembles the leaning
“&" symbol, while LH and progesterone (Pg) values form a "boomerang" shape.
Graphs in this paper were made using data reported by Stricker et al. [Clin Chem Lab
Med 2006;44:883–887]. These patterns were used to construct a simplistic model of
the ovulatory cycle without the conventional "positive feedback" phenomenon. The
model is based on few well-established relations:
– hypothalamic GnRH secretion is increased under estrogen exposure during two
weeks that start before the ovulatory surge and lasts till lutheolysis.
– the pituitary GnRH receptors are so prone to downregulation through ligand
binding that this must be important for their function.
– in several estrogen target tissue progesterone receptor (PgR) expression depends
on previous estrogen binding to functional estrogen receptors (ER), while Pg
binding to the expressed PgRs reduces both ER and PgR expression.
Some key features of the presented model are here listed:
– High GnRH secretion induced by the recovered estrogen exposure starts in the
late follicular phase and lasts till lutheolysis. The LH and FSH surges start due to
combination of accumulated pituitary GnRH receptors and increased GnRH
secretion. The surges quickly end due to partial downregulation of the pituitary
GnRH receptors (64% reduction of the follicular phase pituitary GnRH receptors is
needed to explain the reported LH drop after the surge). A strong increase in the
lutheal Pg blood level, despite modest decline in LH levels, is explained as
delayed expression of pituitary PgRs. Postponed pituitary PgRs expression enforces
a negative feedback loop between Pg levels and LH secretions not before the
mid lutheal phase.
– Lutheolysis is explained as a consequence of Pg binding to hypothalamic and
pituitary PgRs that reduces local ER expression. When hypothalamic sensitivity to
estrogen is diminished due to lack of local ERs, hypothalamus switches back to
the low GnRH secretion rate, leading to low secretion of gonadotropins and to
lutheolysis. During low GnRH secretion rates, previously downregulated pituitary
GnRH receptors recover to normal levels and thus allow the next cycle.
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Possible implications of the presented model on several topics related to
reproductive physiology are shortly discussed with some evolutionary aspects
including the emergence of menopause.Introduction
Perfect timing of several hormone actions during the ovulatory cycle is essential for
complex process of follicular growth, ovulation, and maintenance of corpus luteum.
When presenting the complex dynamic of involved hormones, graphs often show time
series data within an idealized 28 day ovulatory cycle, similar to Figure 1. This ideal
cycle is usually centered on the ovulatory gonadotropin surge (on the day 0), so it starts
with the −14 day and ends with the +13 day. It should be noted that the same data of
time series can be presented as phase plane graphs (Figures 2 and 3) with data points
labeled with days of the ovulatory cycle. This presentation type is potentially better sui-
ted to illustrate the intrinsic dynamic within the shown hormone pairs.
When explaining the sequence of events during the ovulatory cycle, most physio-
logical textbooks are similar in description of two important phases of the ovulatory
cycle: the ovulatory surge of gonadotropins (FSH & LH) and lutheolysis.
Often, more attention is payed to the mechanism of ovulation induction that happens
after several days of raising estrogen blood levels in the late follicular phase. Then an
almost paradoxical surge of gonadotropins, often described as the “positive feedback”,
leads to the follicle rupture. In Boron & Boulpaep [1] this phenomenon is covered with
several related statements “Positive feedback of estrogens, progestins, and activins on the
hypothalamic-pituitary axis is involved in the induction of this LH surge. . . the acceler-
ated rate of increase in estradiol levels in the preovulatory phase sensitizes the gonado-
trophs in the anterior pituitary to GnRH pulses. . . also modulate hypothalamic-15 -13 -11 -9 -7 -5 -3 -1 1 3 5 7 9 11 13










































   

















Figure 1 Conventional time profile graphs of main ovulatory hormones reported by Stricker et al.















































Figure 2 FSH and estrogen values from Figure 1, reported by Stricker et al. [5], shown as a phase
plane graph. Data points are labeled with days of the cycle. They form a pattern that resembles the
leaning “&" symbol. Other published data produced very similar phase plane graphs [4,6-9], so it can be
assumed that any set of ovulatory cycle data would provide similar patterns. This pattern is described in the
The follicular phase to Lutheolysis.
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estradiol induces the midcycle surge of LH and, to a lesser extent, FSH.... Just before ovu-
lation, the rise in estradiol secretion becomes more rapid and, by a positive feedback ef-






































Figure 3 LH and progesterone values from Figure 1, reported by Stricker et al. [5], shown as a
phase plane graph. Data points are labeled with days of the cycle. They form a pattern that resembles a
"boomerang" shape. Other cited data sets of hormonal values produced very similar phase plane graphs of
these two hormones during the cycle This pattern is described in the The follicular phase to Lutheolysis.
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gesterone as well as activin. . . Estradiol secretion by the dominant follicle increases rap-
idly near the end of the late follicular phase. This dramatic rise in circulating estradiol
exerts positive feedback on the anterior pituitary and sensitizes it to GnRH. The net ef-
fect of a rising estradiol level is induction of the LH surge. . ..The LH surge appears to
terminate in part as a result of rising levels of progesterone, via negative feedback, and
in part as a result of loss of the positive feedback that is derived from estradiol. Deple-
tion of gonadotropin stores in the anterior pituitary gland may also contribute to ter-
mination of the LH surge.” (1).
Similar approaches can be found in other textbooks: “ . . .LH secretion is held in check
by the negative feedback effect of the rising plasma estrogen level. At 36 to 48 hours be-
fore ovulation, the estrogen feedback effect becomes positive, and this initiates the burst
of LH secretion (LH surge) that produces ovulation. . .a moderate, constant level of circu-
lating estrogen exerts a negative feedback effect on LH secretion, whereas during the
cycle, an elevated estrogen level exerts a positive feedback effect and stimulates LH
secretion. . .” [2].
Often it is much less said about lutheolysis. In Boron & Boulpaep [1] it is covered
with more elaboration: “The high levels of progesterone, estrogens, and inhibins max-
imally suppress the hypothalamic-pituitary system. The result is that FSH and LH levels
fall. As LH levels fall, the target of LH, the corpus luteum, rapidly diminishes its produc-
tion of estrogen and progestins. . . the fall in estrogen and progestin levels diminishes the
feedback inhibition on the hypothalamic-pituitary system, and gonadotropin secretion
rises once again, thus beginning the next menstrual cycle.”
Here presented model of the ovulatory cycle is an attempt to interpret both gonado-
tropin surges and lutheolysis without using the positive feedback phenomenon. The
model is based on phase plane graphs of gonadotropins with estrogen and progesterone
during a typical ovulatory cycle. This approach was first applied on digitalized values of
FSH, LH, estrogen (E) and progesterone (Pg) during a typical 28-day ovulatory cycle, as
reported by Chabbert Buffet et al. [3]. After that, the arithmetic means of FSH and es-
trogen values reported by Dighe et al. [4] were also tested with this approach. Median
blood values of FSH, LH, estrogen and progesterone provided by Stricker et al. [5] were
used for graphs in this paper. Figure 2 shows that data points in the phase graph of
FSH with estrogen form a pattern that resembles the leaning “&" symbol, while Figure 3
shows that LH and progesterone form a "boomerang" shape phase plane pattern. Other
published data [4,6-9] were used to produce very similar patterns, suggesting that any
set of ovulatory cycle data results in similar hormonal interactions.Basic assumptions behind the proposed interpretation
Several assumptions were needed for the here proposed interpretation of complex
phase plane patterns in Figures 2 and 3.GnRH rhythms and gonadal function
GnRH action is peculiar in two aspects [1,2]. First, it is normally secreted only in a
regular rhythmic pattern and due to limited quantities and short half-life, secretion is
inherently pulsatile. Second, the main GnRH target tissue, the anterior pituitary is
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overexposed to GnRH (or to a synthetic GnRH analogue), a transitory hypogonadism
develops due to downregulation of pituitary GnRHRs that interrupts gonadotropin se-
cretion. This unique susceptibility to downregulation must play some role in the
physiologic gonadotropin secretion.
Inhibin, activin, leptin and other modulators of GnRH secretion
Several mediators are modulating the GnRH secretion. The pineal gland as a biorhythm
regulator probably has some role in initiating puberty, but the body fat reserve seems
more important in human reproduction. Information about the body fat reserve is
probably mediated through leptin secretion from adipose tissue, particularly from the
abdominal fat [10]. Only sufficient leptin exposure allows reproduction through hypo-
thalamic leptin action. Low fat reserve in childhood and in anorectic patients prevent
normal gonadotropin secretion.
The rhythm of GnRH secretion depends on hypothalamic action of sex hormone ac-
tion, as shown in Table 1. In women regulation of GnRH secretion is complex. Two
rhythms interchange during each of near 400 successive ovulatory cycles during the fer-
tile period between puberty and menopause. Slower rhythm of GnRH secretion lasts
during the follicular phase (from lutheolysis to preovulatory days), while the rhythm
gets faster before ovulation and remains fast during the lutheal phase and slows again
in lutheolysis [2]. Noting two things is important. The first is that shifts in GnRH secre-
tion are expected only in women, they happen in lutheolysis and preovulatory and are
compensated by changes in the availability of GnRH receptors within the followingTable 1 Here proposed different settings of leptin and GnRH actions during different
phases of growth and aging and in anorexia nervosa
Phases of growth & aging GnRH rhythm and GnRHR availability
Leptin GnRH Female Male
Children low secretion minimal secretion
receptors normal or increased pituitary receptors
Early pubertal normal secretion intermediate secretion
receptors normal pituitary receptors
Healthy adult normal secretion low secretion from lutheolysis through
follicular phase till the preovuatory days
stable
high secretion from preovulatory days
till lutheolysis
receptors slowly up-regulated pituitary
receptors during preovulatory days
due to low GnRH exposure
stable
rapid downregulation of pituitary
receptors during the ovulatory




normal secretion low secretion due to estrogen deprivation not applicable
receptors increased pituitary receptors due to low GnRH
exposure leading to high FSH and LH secretion
Anorexia nervosa low secretion minimal secretion
receptors normal or increased pituitary receptors
It is important to note that shifts in GnRH secretion are expected only in women, they happen in lutheolysis and
preovulatory and are compensated by changes in the availability of GnRH receptors within the following days. This
might explain the unique susceptibility to downregulation of the GnRH pituitary receptors.
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itary receptors. The second important feature is that period of high GnRH secretion
starts hours before the ovulatory surge and last till lutheolysis. This timing and dur-
ation prove that this shifting between two levels of GnRH secretion in female hypo-
thalamus is surely important for the ovulatory surge, but it cannot explain it entirely.
Based only on this shifting, one might expect only that in the late follicular phase go-
nadotropin secretion will rise and remain indefinitely stable on an elevated level, a
situation quite analogous to the male setting in Table 1. No ovulation can be expected
based only on increased GnRH secretion from the preovulatory days till lutheolysis.
In males after the puberty onset, stable GnRH secretion lasts for decades (Table 1).
Interactions of GnRH and gonadotropins with testosterone and inhibins are explained
as simple control loops of negative feedback. Although due to presence of hypothal-
amic androgen receptors [2] direct androgen effects on male hypothalamus are
expected, some estrogen is also locally produced from testosterone and this can act as
an important regulator of GnRH secretion, similar as in women.
If we take gonadotropins more closely, the regulation of LH secretion seems simple.
In men, it depends on testosterone action on the pituitary and on the previously men-
tioned combined testosterone/estrogen exposure that modulates hypothalamic GnRH
secretion. In women it seems mainly regulated by progesterone exposure, although dur-
ing the follicular phase it is regulated through GnRH actions with FSH.
FSH regulation is more complex. In men, beside the combined testosterone/estrogen
modulation of hypothalamic GnRH secretion, FSH is regulated on the pituitary level by
inhibin secreted from Sertoli cells [1,2]. In women, beside hypothalamic GnRH action,
FSH depends on several hormones that act on the pituitary level. These are estrogen,
inhibin A and inhibin B, activin etc. In describing actions of these regulators of FSH se-
cretion, several issues seem important:
– Estrogen binds to the pool of sex hormone binding globulin [1,2] and this binding
alters estrogen availability to target tissues, particularly when this pool is empty, as
happens during the follicular phase. This might explain the importance of inhibin B
in preventing multiple ovulations [11]
– inhibin A is secreted during the lutheal phase when it reduces FSH secretion [12]
and thus limit the recruitment of primordial follicles for maturation in the
following cycles. This might be related to the statements in Boron & Boulpaep [1]
that “. . .the monthly cycle of folliculogenesis actually begins from the primary-follicle
stage 2 to 3 days before onset of the menses of the previous cycle. At this time, FSH
levels begin to increase because of decreasing inhibin concentrations, thus inducing
folliculogenesis, which is completed in the next cycle.”.
– activin is probably another fine-tuning modulator of the FSH secretion.
Comparison of ovulatory cycle and puberty
Regular shifting between the low and the high mode of GnRH secretion each two
weeks in ovulating women resembles the puberty onset in several aspects (Table 1). Al-
though some GnRH is secreted in childhood, prepubertal pituitaries in boys and girls
seem to remain refractory until puberty [1,2] and this low GnRH secretion rate seems
analogous to the follicular phase GnRH secretion.
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both genders, particularly leptin and kisspeptin [13]. Since preovulatory changes in GnRH
secretion are related to the increased exposure of hypothalamus to circulating estrogen, it
seems plausible that hypothalamic estrogen exposure might be a decisive factor of enter-
ing puberty in both genders after priming with leptin, kisspeptin and other factors.
Interplay between sex hormone receptors and ligands
Estrogen exposure increases expression of progesterone receptors
From breast cancer studies [14-19], it is well established that progesterone receptor
(PgR) expression in cells with estrogen receptors (ER) depends on estrogen exposure
during previous days. Similar effect of estrogen administration on pituitary PgR expres-
sion has also been reported [20].
Based on reports on various estrogen and progesterone target tissues (human uterus [21],
endometrial hyperplasia [22,23], rat hypothalamic and limbic nuclei [24], anterior pituitary
of rats [25,26], target organs in the female rat [27-29]), it is here proposed that without
binding of various ER ligands (estradiol (E2) and probably some estrone (E1) locally con-
verted from androgens), PgR expression remains low in pituitary and hypothalamus.
An indirect evidence for this proposition might lie in the known fact that medium
and high dose progesterone-only contraceptive pills can prevent ovulation, while this
cannot be achieved with low doses of progesterone alone [30]. This is also mentioned
in Boron & Boulpaep [1]: “. . .estrogens exert negative feedback at both low and high
concentrations, whereas the progesterins are effective only at high concentrations". A
possible explanation is that during the follicular phase a sufficient progesterone action
is needed to prevent ovulation. Without estrogen action that increases expression of pi-
tuitary PgRs, available receptors are scarce and this lack of PgRs makes gonadotropin
secreting cells less sensitive to progesterone exposure.
Progesterone exposure reduces both ER and PgR expression
It is mentioned in Boron & Boulpaep [1] that “ . . .progesterone may act centrally by
inhibiting gonadotropin secretion. Progestins are also antiestrogens. As a result, proges-
tins acting locally may downregulate estrogen receptors and reduce the effectiveness of
estradiol.” Several reports show that progesterone exposure diminishes both ER and
PgR expression in target tissues. Vereide et al. [29] have found in uterine mucosa that
gestagen reduces glandular and stromal PgRs and ERs. Lundgren et al. [16] have
reported that high dose oral gestagen diminishes PgRs, reduces ERs and androgen
receptors in the breast cancer tissue.
Di Carlo et al. [26] showed that high doses of medroxyprogesterone acetate caused a
very evident reduction in the weight of pituitary glands, suggesting that gestagens alter
the hypothalamic-pituitary function.Proposed levels of regulation in the model
The model presumes that the GnRH shifting depends on simple interactions of ovula-
tory hormones and their hypothalamic receptors, although it might turn out to be
much more complex in reality. It proposes that expression of hypothalamic and pituit-
ary ERs and PgRs depends on binding of estrogen and progesterone to their receptors
(Table 2). Estrogen exposure induces expression of new PgRs, while progesterone
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be a consequence of progesterone binding that reduces expression of ERs. When hypo-
thalamic sensitivity to estrogen is sufficiently reduced, hypothalamus switches back to
the low GnRH secretion rate.
At the hypothalamic level, the GnRH secretion rate depended on the detection of
circulatory estrogens, so increased presence of hypothalamic ER due to low estrogen
levels during the early follicular phase allows detection of rising estrogen secretion
from growing follicles. As previously described, sufficient estrogen exposure shifts
GnRH secretion to the high rate and this change is not the “positive feedback”
phenomenon, since the high GnRH secretion rate is stable and lasts several days, much
longer than the ovulatory surge.
During the lutheal phase, due to E and Pg exposure, hypothalamic ER and PgR are
diminished until the estrogen exposure becomes undetectable. This change in hypo-
thalamic sensitivity to circulating estrogens shifts the GnRH secretion rate to the low
secretion that causes rapid lutheolysis.
On the pituitary level, gonadotropin secreting cells depend on GnRH action. Since
the pituitary GnRHRs are increased during the follicular phase, increased GnRH secre-
tion will maximally increase gonadotropin secretion until GnRHRs are spent and this
partial downregulation of pituitary GnRHRs limits duration of the gonadotropin surge.Description of the proposed ovulatory cycle interpretation
This description is based on phase plane patterns from Graphs 2 and 3. Since precise
blood values of other ovulatory cycle hormones are not available, the model is deliber-
ately simplified to involve only these four hormones, namely FSH with estrogen and
LH with progesterone. This model also lacks possible influences of estrogen, progester-
one and activins on sensitivity of the pituitary gland to GnRH probably via changing
the number of pituitary GnRH receptors. Nevertheless, all omitted plausible or possible
interactions are not expected to contradict the here proposed simplistic model. In fact,
it is expected that actions of in the model omitted hormones are not important for theTable 2 The proposed interpretation of ligand interactions with their receptors
Ligand exposure Changes in receptor availability Consequence of
sustained ligand exposureER availability PgR availability
no ligands increased scarce increased sensitivity to estrogen
and reduced to progesterone
due to lack of estrogen action
only ER ligands normal or decreased increased estrogen action enhances
progesterone sensitivity due to
increased PgR expression
only progesterone decreased decreased prolonged exposure to
progesterone reduces
sensitivity both to estrogen and
progesterone due to reduced ER
receptor synthesis that diminishes




Estrogen action on estrogen receptors (ER) is variable and acts as a prerequisite of progesterone receptor (PgR)
expression. On the other hand, the progesterone actions are inherently limited, since sustained progesterone binding
reduces both PgR and ER availability, leading to reduced sensitivity both to estrogen and progesterone.
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these three key relations:
– Hypothalamic GnRH secretion is increased under estrogen exposure during two
weeks that start before the ovulatory surge and lasts till lutheolysis.
– The pituitary GnRH receptors are so prone to downregulation through ligand
binding that this must be important for their function.
– In several estrogen target tissues, PgR expression depends on previous estrogen
binding to functional ERs, while Pg binding to the expressed PgRs reduces both ER
and PgR expression.The follicular phase
During the first four days (days of menstrual bleeding), the pool of estrogen binding
proteins slowly releases estrogen accumulated from the previous cycle. In the next days,
levels of inhibin, E and Pg are low, allowing FSH to rise. Early estrogen secretion can-
not suppress the FSH secretion since most of the new estrogen is caught by the almost
empty pool of sex hormone binding globulin (SHBG). Excess FSH secretion that might
lead to multiple ovulations is prevented by inhibin.
On the day −7, new follicles start producing more estrogen and inhibin B. From the
day −6 to −2, due to estrogen secretion from the dominant follicle, estrogen rapidly
rises. Despite expected suppression, FSH is only slightly reduced, showing absence of
the negative feedback of FSH with estrogen. A possible interpretation is that secreted
estrogen binds to the unsaturated pool of plasma binding proteins. Inhibin B is prob-
ably important in preventing multiple ovulation due to inhibition of FSH secretion.
Between the day −3 and −1, estrogen action in the hypothalamus is strong enough to
switch the GnRH secretion rhythm to a more intense level that forces rapid rises of
FSH and LH secretions during one or two days, peaking on the day 0. The FSH peak is
limited by pituitary exposure to estrogen and inhibin A & B through the negative feed-
back. The LH surge seems limited only by the GnRH action, since Pg level in the blood
is low and the pituitary PgRs are still scarce. Expression of PgR was low due to low es-
trogen exposure during the previous week. The LH surge can be used as a measure of
increased GnRH secretion since, median LH values reported by Stricker et al. [5] are
5.8 times increased (based on 41.19/7.02 from the reported data). This ratio is much
lower in the FSH secretion due to pituitary sensitivity to estrogen and inhibins.
Intensified GnRH secretion rapidly downregulates the pituitary GnRH receptors and
this reduction in pituitary GnRH sensitivity diminish both gonadotropin surges. Based
on median values reported by Stricker et al. [5], the LH surge decline can be explained
as a profound downregulation of GnRH receptors, leaving only some 36% of preovula-
tory pituitary GnRH receptors present after downregulation (based on 14.92/41.19
x100, from the reported data).
In short, ovulatory surges are here not explained by the “positive” feedback. Instead
of that, the low GnRH secretion during the follicular phase allows the pituitary
GnRHRs to accumulate. When the GnRH secretion is qualitatively increased, due to es-
trogen exposure, temporary gonadotropin surges happen. They last until the GnRHR
downregulation returns the gonadotropin secretion under the negative feedback
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serial hormonal actions:
Early follicular phase:
– low estrogen exposure increases pool of hypothalamic ERs
– low GnRH secretion increases pool of pituitary GnRHRs
Late follicular phase
– hypothalamus detects estrogen secretion and changes GnRH secretion to the high rate
Ovulatory surges
– surges of gonadotropins last until pituitary GhRHRs are downregulated
– the FSH surge is shaped by estrogen and inhibin negative feedback
– the LH surge is maximal since pituitary is insensitive to low progesterone exposure
due to low pituitary PgR expressionOvulation
The dominant follicle ruptures and subsequent local bleeding interrupts estrogen pro-
duction. In the first postovulatory day (day +1), beside FSH and LH that fail due to
downregulation of pituitary GnRH receptors, estrogen levels also fall due to interrupted
ovarian secretion, but this fall is buffered by liberating some of SHBG bound estrogen.The lutheal phase
FSH & estrogen
For FSH secretion, a new balance between GnRH secretion, pituitary GnRH sensitivity
on one and estrogen (and inhibin A) exposure on the other side is reached on the day
+3. Between days +3 and +9, a negative feedback between FSH and estrogen is estab-
lished, during which increased estrogen secretion reduces the FSH secretion.
LH & progesterone
Delayed estrogen action on pituitary and hypothalamic levels (started on days −7 to −2)
leads to the delayed PgR expression and results in the lack of clear negative feedback
between LH and progesterone. It is evident between days +1 and +4, when progester-
one level strongly rise, despite slowly decreasing LH levels. On the day +5 to +9, the
negative feedback of LH and progesterone steps in, LH drops due to progesterone ac-
tion. Pg levels peak on day +7 and after that both Pg and LH decline.Lutheolysis
On the day +10, a small drop of FSH is followed by a huge drop of estrogen on the
next day, showing that the hypothalamic switch to the low GnRH secretion rate has
just happened. Lutheolysis happens on days +11 to +14. LH secretion hits the bottom
on the day +11, and progesterone drops almost to the nonexistent levels at the cycle
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crease in FSH secretion, despite low GnRH secretion rates, suggesting initial recovery
of pituitary GnRH receptors.Possible implications of the proposed interpretation on female and male
reproductive physiology
The presented simplified ovulatory cycle model is possibly related to several topics in
reproductive physiology.Possible actions of adrenal androgens in women
When considering possible roles of androgens in women, androgens on the pituitary level
act twice: via androgen receptors, androgens regulate the LH secretion, but also and after
being locally transformed to E1, they indirectly regulate the FSH secretion. So, increased
extragonadal androgen exposure can block follicle maturation and prevent ovulation by
suppressing FSH and LH surges, and thus can lead to polycystic ovaries.
Several entities seem linked to the role of adrenal steroids in women:
– Anorexia nervosa. Low gonadotropin levels are reported in this disorder [30]. It is
possible that diminished fat reserves do not secrete enough leptin and not convert
enough adrenal androgens to estrogen. A combined estrogen and leptin deprivation
reduces GnRH secretion, resembling a prepubertal situation [31] in which
hypothalamus becomes refractory to all stimuli, if the body fat is very low.
– Menopause. In menopausal women, adrenal androgens are converted to estrone in
the adipose tissue. Postmenopausal estrogen action is to low to to suppress the FSH
secretion, or to enhance the hypothalamic GnRH secretion. Since GnRH secretion
remains low, pituitary GnRH receptors accumulate and thus increase the pituitary
sensitivity to GnRH. Despite low GnRH secretion rate, due to increased pituitary
sensitivity LH and FSH blood values are increased to the menopausal range. Beside
that, low estrogen exposure of various target tissues lead to an increased ER and
diminished PgR expression, making them more vulneable to estrogen related
neoplasms, due to unopposed easrogen actions on them.Possible differences between the “female” and “male” hypothalamus
It is well recognized that the “male” hypothalamus is not able to generate ovulatory
FSH and LH surges. Here presented interpretation proposes that the “female” hypothal-
amus is programed to act in two distinct modes of GnRH secretion. The low secretion
period lasts from lutheolysis (day +10), till the late follicular phase (day-2), while the
high rate period starts from the preovulatory phase (day −1) to lutheolysis (day +9).
This two-mode mechanism allows increased pituitary sensitivity to GnRH on the day 0,
responsible for the ovulatory surge. On the other hand, lutheolysis is caused by reduced
hypothalamic sensitivity to estrogen that develops at the end of the lutheal phase, due
to several days of progesterone exposure that diminishes both ER and PgR expression.
This interpretation also relies on the available pool of sex hormone binding globulin
(SHBG). Presence of a large SHBG pool would postpone ovulation since estrogen se-
cretion first saturates SHBG before exerting a decisive action on the hypothalamic level.
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reduced by androgens, so in males a small and stable SHBG pool is expected, while in
women the SHBG availability depends on estrogen action in the previous cycle.Anastrasole and gonadal disorders
Anastrosole, an aromatase inhibitor used in the treatment of ER positive breast cancer,
is also used to control gynecomastia in boys [32] and in hypogonadic male adults [33].
In older men anastrasole can increase both testosterone and gonadotropin levels by re-
ducing estrogen formation in adipose tissues. This can be explained if exposure to
extragonadal estrogen was so intense that it gradually increased the GnRH secretion
rate, until the GnRH pituitary receptors were so much downregulated that this resulted
in low gonadotropin and testosterone levels.
Extremely obese male patients often have hypogonadism with low gonadotropin
levels [34] and anastrasole can normalize gonadotropin secretion by inhibiting tissue
aromatase. A plausible interpretation is that this disorder is caused by hypothalamic
overexposure to extragonadal estrogen that alters GnRH secretion until downregulation
of pituitary GnRH receptors diminishes gonadotropin secretion. This would result in a
setting analogous to the castration by using a GnRH analogue.Evolutionary aspects of the proposed ovulatory cycle interpretation
Potential evolutionary survival advantages of interactions proposed in the described
ovulatory cycle model are here briefly outlined. Since in many mammals daytime light
exposure initiates estrous cycles in which ovulation is directly linked to the intercourse,
conception and pregnancy are almost inevitable. The lack of seasonal reproduction in
our species might suggest that we have evolved somewhere near the equator, where the
lack of seasons could make the pineal gland control unimportant in our reproduction.
Without seasonal estrous type reproduction, the probability of pregnancy declined
sharply in our ancestors, leading to regular ovulatory cycling and frequent intercourses
unrelated to ovulations. This evolutionary pressure for frequent ovulations forced our
species to develop regular 28-day ovulatory cycles, probably as short as possible to allow
pregnancy. The result is that reproduction of our species started to depend on the abil-
ity of our female ancestors to have regular ovulations and intercourses whenever it was
energetically feasible.
In other words, it became unavoidable to our female ancestors to reproduce only dur-
ing periods of normal food availability [35]. We can assume that in variable long peri-
ods of near starvation, surviving of our female ancestors required a transitory phase of
hypogonadism, analogous to the endocrine setting seen in anorexia nervosa. This meta-
bolic control over female reproduction is mediated through leptin action on the hypo-
thalamus. During periods of low leptin exposure, no chances of pregnancy exist due to
absence of ovulations and reduced libido. Energy and protein sparing in all estrogen
target tissues, particularly in breasts and uterine mucosa enhance chances of survival
during the harsh period.
With normal food availability, the whole system recovers. If no pregnancy has occurred
within the optimal time frame of the lutheal phase, the lutheal progesterone secretion
turns down both ER and PgR expression and leads to lutheolysis and further cycles.
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women. From the evolutionary perspective each mediator of FSH secretion during the
ovulatory cycle has to have some survival advantage for our ancestors, otherwise it
would probably be lost during evolution.
It seems plausible that mediators of FSH secretion function as optimizer of continuos
cycling. For instance, to many primordial follicles are recruited in each ovulatory cycle,
the ovarian reserves can be quickly depleted. If we are considering some 500.000 prim-
ordial follicles at the puberty age, a normal woman would spend some 1000 follicles in
each cycle. So, the primordial follicle recruitment has to be limited to allow more ovu-
lations. This is a potential role of inhibin A that tunes down the FSH secretion in the
lutheal phase and thus spare some primordial follicles from activation. The other issue
is that if more than one follicle matures, this might lead to dangerous multiple preg-
nancies that result in risky delivery of immature babies. Evolutionary response was the
inhibin B action that tunes down the FSH secretion in the follicular phase and thus
allows mainly single pregnancies.
An interesting consequence of this interpretation is that menopause might not be
caused by the advantageous role of postmenopausal women in the care of their grand-
children, as proposed by G.C. Williams [36]. The main objection, mentioned by Wil-
liams in the cited paper [36] is that among our ancestors, very few women lived more
than 40 years. Becoming postmenopausal must have been a rare event among our fe-
male ancestors. The expected few able grandmothers could not impose a substantial
survival advantage that would result in the universal occurrence of menopause in all
women after a certain age.
Due to these remarks, the menopause, as a strict gender specific feature of our spe-
cies, needs to be explained within the frames of female reproductive physiology. Fur-
ther, the increased importance of postmenopausal women in family life of our
ancestors should be considered a consequence of physiology and not the cause.
Here proposed interpretation is that the ovarian pool of primordial follicles was opti-
mized in our ancestors to allow sufficient chances of reproduction despite continuous
ovarian activity. When sufficient reproductive probability was once achieved, there was
no need for further enlargements of the primordial follicle pool in ovaries. After the
average lifespan of our ancestors has become prolonged, the menopause has emerged
because of normal depletion of ovarian reserves of primordial follicles.
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